Predictive value of pretreatment PD-L1 expression in EGFR-mutant non-small cell lung cancer: a meta-analysis.
Zhiyu PengHuahang LinKe ZhouSenyi DengJiandong MeiPublished in: World journal of surgical oncology (2021)
The result of this meta-analysis suggested that PD-L1 expression might be a predictive biomarker for EGFR-mutant non-small cell lung cancer treated with EGFR-TKIs.